A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis

BACKGROUND: Tocilizumab (TCZ) is humanized monoclonal antibody against the interleukin-6 (IL-6) and receptor that has prominent efficacy for the treatment of rheumatoid arthritis (RA). We conducted a retrospective observational study to determine how long TCZ controls RA. PATIENTS AND METHODS: We re...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Nobuyasu, Shimizu, Toshiki, Ishiura, Yoshihisa, Amuro, Hideki, Nishizawa, Tohru, Tamaki, Takeshi, Nomura, Shosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352638/
https://www.ncbi.nlm.nih.gov/pubmed/34385832
http://dx.doi.org/10.2147/JIR.S323577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352638/
https://www.ncbi.nlm.nih.gov/pubmed/34385832
http://dx.doi.org/10.2147/JIR.S323577

Ejemplares similares